EFFECTS OF ORAL-ADMINISTRATION OF A STIMULATOR FOR NERVE GROWTH-FACTOR SYNTHESIS IN BASAL FOREBRAIN-LESIONED RATS

Citation
A. Nitta et al., EFFECTS OF ORAL-ADMINISTRATION OF A STIMULATOR FOR NERVE GROWTH-FACTOR SYNTHESIS IN BASAL FOREBRAIN-LESIONED RATS, European journal of pharmacology, 250(1), 1993, pp. 23-30
Citations number
34
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00142999
Volume
250
Issue
1
Year of publication
1993
Pages
23 - 30
Database
ISI
SICI code
0014-2999(1993)250:1<23:EOOOAS>2.0.ZU;2-M
Abstract
Nerve growth factor plays an important role in the survival and mainte nance of cholinergic neurons in the central neuronal system. In senile dementia of the Alzheimer type, learning and memory are impaired by t he loss of neurons in the magnocellular cholinergic neuronal system. I t is, therefore, of interest to investigate the role of nerve growth f actor in senile dementia of the Alzheimer type. We now found that -(4- hydroxybutyl)-2,3,5-trimethyl-1,4-benzoquinone (TMQ) stimulates nerve growth factor synthesis in mouse astroglial cells and that the compoun d has improving effects on memory and choline acetyltransferase activi ty in basal forebrain-lesioned rats, an amnesia animal model. TMQ amel iorated amnesia in the water maze and passive avoidance tasks. The com pound not only restored the reduced choline acetyltransferase activity in the parietal cerebral cortex, but also increased nerve growth fact or content and choline acetyltransferase activity in the hippocampus, although it did not change either of these parameters in any brain reg ion in intact rats. These results suggest that the compound activates cholinergic neurons only in the damaged brain and, further, indicate t hat nerve growth factor stimulators could be used in clinical trials f or the treatment of senile dementia of the Alzheimer type.